JACOBS LEVY EQUITY MANAGEMENT, INC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 77 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$17,666
-94.3%
106,743
-66.7%
0.00%
-100.0%
Q1 2023$312,608
-7.2%
320,295
-1.1%
0.00%0.0%
Q4 2022$336,773
-25.5%
323,820
-17.6%
0.00%
-50.0%
Q3 2022$452,000
+56.9%
392,871
+155.3%
0.00%
+100.0%
Q2 2022$288,000
-67.5%
153,891
-10.2%
0.00%
-66.7%
Q3 2021$886,000
-36.0%
171,428
-52.6%
0.01%
-33.3%
Q2 2021$1,384,000
-0.4%
361,434
-33.2%
0.01%
-18.2%
Q1 2021$1,390,000
+4.0%
540,766
+1.2%
0.01%
-8.3%
Q4 2020$1,336,000
+69.1%
534,397
+40.0%
0.01%
+50.0%
Q3 2020$790,000
-14.4%
381,649
+28.2%
0.01%
-20.0%
Q2 2020$923,000
+34.4%
297,716
-1.2%
0.01%
+11.1%
Q1 2020$687,000
-27.5%
301,436
+15.3%
0.01%0.0%
Q4 2019$947,000
+122.8%
261,517
+110.0%
0.01%
+80.0%
Q3 2019$425,000
-43.9%
124,517
-22.8%
0.01%
-50.0%
Q2 2019$758,000
+34.9%
161,252
-3.9%
0.01%
+25.0%
Q1 2019$562,000
+161.4%
167,839
+294.9%
0.01%
+166.7%
Q2 2018$215,000
+131.2%
42,501
+245.5%
0.00%
+50.0%
Q4 2017$93,00012,3000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders